Rhophylac 300 MCG/2 ML syringe 2ML
Ended Awarded
- Contract number
- SPE2DB25FVLX6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,721
Award facts
- Contract value 100% obligated
- $1,720.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Rhophylac 300 mcg/2 mL syringes with a ceiling value of $1,720.80 and a firm fixed price structure. The contract is not set-aside and represents a competitive award to the pharmaceutical distributor. Performance will be completed by October 10, 2025, with fulfillment occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.999 billion comprehensive pharmaceutical supply vehicle running through December 2026 that enables the company to provide pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, regularly fulfills delivery orders for specialized medical commodities through its DLA contract vehicle. As a for-profit organization registered in the System for Award Management, the company maintains an extensive portfolio of federal medical product deliveries spanning vaccines, specialty medications, brand-name and generic drugs, and related medical supplies across multiple therapeutic domains. The Rhophylac supply order under this award supports the Defense Health Agency and broader military healthcare systems' immunological treatment needs. The company's federal contract performance history demonstrates consistent capability to meet competitive procurement requirements through firm fixed-price delivery arrangements across varying order values.
Quick answers
Who was awarded contract SPE2DB25FVLX6?
SPE2DB25FVLX6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 19, 2025.
How much is contract SPE2DB25FVLX6 worth?
The government has obligated $1,721 on SPE2DB25FVLX6.
Is contract SPE2DB25FVLX6 an order under another contract?
Yes. SPE2DB25FVLX6 is a delivery order under SPE2DB22D1202, an indefinite delivery contract.
Was contract SPE2DB25FVLX6 competed?
The extent of competition for SPE2DB25FVLX6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award